24/7 Market News Snapshot 01 August, 2025 – I-MAB American Depositary Shares (NASDAQ:IMAB)
DENVER, Colo., 01 August, 2025 (www.247marketnews.com) – (NASDAQ:IMAB) are discussed in this article.
I-MAB, a biopharmaceutical company, has recently demonstrated substantial stock market momentum with its American Depositary Shares (ADS), which opened today at $2.50 and surged more than 25.22% to a current trading price of $2.517, up from a previous close of $2.010. This robust increase reflects heightened interest from investors and signals a strong confidence in the company’s growth prospects. The trading volume has reached 2.18 million shares, indicating vigorous market activity and a high demand for I-MAB’s stock, as investors keenly monitor its trajectory.
Compounding this positive sentiment, Everest Medicines has announced a strategic equity investment of approximately $30.9 million in I-MAB, effectively securing a 16.1% stake in the company. This investment is viewed as a critical step towards advancing I-MAB’s oncology pipeline, including the innovative bispecific antibody Givastomig, which has shown promising results with an overall response rate (ORR) of 83% in recent Phase 1b trials targeting first-line gastric cancers when administered with immunotherapy.
Rogers Yongqing Luo, CEO of Everest Medicines, emphasized that this collaboration aligns I-MAB’s unique clinical capabilities with Everest’s established presence in Asian markets, presenting an opportunity to foster complementary growth in oncology developments. The strategic investment has been further bolstered by notable participation from major financial entities, including Janus Henderson Investors and Adage Capital Partners LP.
Together, Everest and I-MAB are positioned to enhance their clinical and business synergies, paving the way for accelerated development in immuno-oncology and the potential to revolutionize treatment solutions. This partnership stands as a testament to their commitment to addressing critical unmet medical needs in cancer care globally.